Suppr超能文献

相似文献

1
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.
Neurology. 2008 May 6;70(19 Pt 2):1850-7. doi: 10.1212/01.wnl.0000304041.09418.b1. Epub 2008 Apr 9.
2
Imaging correlates of pathology in corticobasal syndrome.
Neurology. 2010 Nov 23;75(21):1879-87. doi: 10.1212/WNL.0b013e3181feb2e8.
3
Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Neuropathology. 2009 Oct;29(5):566-73. doi: 10.1111/j.1440-1789.2009.01017.x. Epub 2009 Apr 21.
5
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
Neurology. 2010 Dec 14;75(24):2212-20. doi: 10.1212/WNL.0b013e31820203c2.
6
TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
Neurology. 2010 Dec 14;75(24):2204-11. doi: 10.1212/WNL.0b013e318202038c.
7
TDP-43 is a key player in the clinical features associated with Alzheimer's disease.
Acta Neuropathol. 2014;127(6):811-24. doi: 10.1007/s00401-014-1269-z. Epub 2014 Mar 23.
8
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.
Neurology. 2008 Jan 1;70(1):25-34. doi: 10.1212/01.wnl.0000287073.12737.35.
9
MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration.
Neurodegener Dis. 2009;6(3):106-17. doi: 10.1159/000209507. Epub 2009 Mar 19.
10
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
Ann Neurol. 2007 May;61(5):435-45. doi: 10.1002/ana.21154.

引用本文的文献

3
Stathmin-2 enhances motor axon regeneration after injury independent of its binding to tubulin.
Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2502294122. doi: 10.1073/pnas.2502294122. Epub 2025 May 20.
4
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.
Mol Neurodegener. 2025 May 8;20(1):53. doi: 10.1186/s13024-025-00839-8.
9
Evaluating the updated LATE-NC staging criteria using data from NACC.
Alzheimers Dement. 2024 Dec;20(12):8359-8373. doi: 10.1002/alz.14262. Epub 2024 Oct 1.

本文引用的文献

1
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
Acta Neuropathol. 2007 Sep;114(3):221-9. doi: 10.1007/s00401-007-0261-2. Epub 2007 Jul 25.
2
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.
Am J Pathol. 2007 Jul;171(1):227-40. doi: 10.2353/ajpath.2007.070182.
3
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
Ann Neurol. 2007 May;61(5):435-45. doi: 10.1002/ana.21154.
4
TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.
Brain. 2007 May;130(Pt 5):1386-94. doi: 10.1093/brain/awm065. Epub 2007 Apr 17.
6
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
Brain. 2007 Mar;130(Pt 3):708-19. doi: 10.1093/brain/awl388. Epub 2007 Jan 31.
7
Frontotemporal lobar degeneration without lobar atrophy.
Arch Neurol. 2006 Nov;63(11):1632-8. doi: 10.1001/archneur.63.11.1632.
9
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Science. 2006 Oct 6;314(5796):130-3. doi: 10.1126/science.1134108.
10
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.
Acta Neuropathol. 2006 Nov;112(5):539-49. doi: 10.1007/s00401-006-0138-9. Epub 2006 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验